Browse > Article

Statistical Analysis of 1,000 Cases of Kawasaki Disease Patients Diagnosed at a Single Institute  

Hwang, Dae Hwan (Department of Pediatrics, Yonsei University College of Medicine)
Sin, Kyoung Mi (Department of Pediatrics, Yonsei University College of Medicine)
Choi, Kyong Min (Department of Pediatrics, Yonsei University College of Medicine)
Choi, Jae Young (Department of Pediatrics, Yonsei University College of Medicine)
Sul, Jun Hee (Department of Pediatrics, Yonsei University College of Medicine)
Kim, Dong Soo (Department of Pediatrics, Yonsei University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.4, 2005 , pp. 416-424 More about this Journal
Abstract
Purpose : To find the risk factors associated with coronory artery lesions, non-responsiveness to intravenous immunoglobulin(IVIG) treatment, and recurrences in Kawasaki disease patients. Methods : We retrospectively analyzed 1,000 Kawasaki disease patients who were admitted to Yonsei University Medical Center from September 1990 to December 2003. We compared between responder and non-responder groups to IVIG treatment as well as between relapsed and non-relapsed groups, and as to the relapsed group, we also compared variables between patients in their first and second attack states. Finally, factors associated with longer-fever duration from disease onset were evaluated. Results : Longer fever durations before and after IVIG treatment, male sex, lower Hgb and Hct level, higher WBC count and segmented WBC proportion, and higher CRP and Harada's score were related with coronary artery lesions. Non-responsiveness was related to higher WBC count, segmented WBC proportion, CRP, SGPT, Harada's score, and pyuria. Moderate-to-severe coronary artery dilatations and recurrences were more commonly seen among the non-responder group. No significant predictive factors for recurrence were found. In the relapsed group, lower WBC count, CRP, and shorter fever duration from disease onset were observed in their second attack state. Fever duration from disease onset showed positive correlation with WBC count, CRP, and Harada's score and negative correlation with Hgb levels. Conclusion : Higher WBC count, CRP, and higher Harada's score were related to both higher incidences of coronary artery lesions and non-responsiveness to IVIG treatment, and these factors were also related with longer fever duration. Non-responders to IVIG treatment showed higher recurrence rate and more moderate-to-severe coronary artery dilatations than responders.
Keywords
Mucocutaneous lymph node syndrome; Intravenous immunoglobulins; Risk factors; recurrence; Treatment outcome; Treatment failure;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy 1967;16:178-222
2 Wright DA, Newburger JW, Baker A, Sundel RP. Clinical and laboratory observations. Treatment of immunoglobulinresistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;128:146-9   DOI   ScienceOn
3 Fujiwara T, Fujiwara H, Hamashima Y. Frequency and size of coronary arterial aneurysm at necropsy in Kawasaki disease. Am J Cardiol 1987;59:808-11   DOI   ScienceOn
4 Kato H, Koike S, Yokoyama T. Kawasaki disease : Effect of treatment on coronary artery involvement. Pediatrics 1979;63:175-9
5 Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2:1055-8
6 Onouchi Z, Tomizawa N, Goto M, Nakata K, Fukuda M. Cardiac involvement and prognosis in acute mucocutaneous lymph node syndrome. Chest 1975;68:297-301   DOI   ScienceOn
7 Kijima Y, Kamiya T, Suzuki A, Hirose O, Manabe H. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn Circ J 1982;46:1239-42   DOI   ScienceOn
8 Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med 1995;149:779-83   DOI   ScienceOn
9 Lee DB. Epidemiologic study of Kawasaki disease in Korea (1976-1984). J Cath Coll 1985;38:8-19
10 Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-7
11 Hiraishi S, Yashiro K, Oguchi K, Kusano S, Ishii K, Kakazawa K. Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome; Relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol 1981;47:323-30   DOI   ScienceOn
12 Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, et al. Fate of coronary aneurysms in Kawasaki disease : Serial coronary angiography and long-term follow up study. Am J Cardiol 1982;49:1758-63   DOI   ScienceOn
13 Kim NY, Chang CH, Lee DS, Kim DK, Choi SM, Kim WT. A clinical study of intravenous gammaglobulin retreatment in Kawasaki disease. J Korean Pediatr Soc 2000; 43:223-8
14 Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matsumoto Y, et al. Prediction of non-responsiveness to intravenous high-dose $\gamma$-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000;137: 172-6   DOI   ScienceOn
15 Engle MA, Nunzia NS, Bussel JB. Clinical trial of singledose intravenous gamma globulin in acute Kawasaki disease. Am J Dis Child 1989;143:1300-4
16 Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;128:146-9   DOI   ScienceOn
17 Kato H, Ichinose E, Yoshioka, Takechi T, Matsunaga S, Suzuki K. Fate of coronary aneurysm in Kawasaki disease. Am J Cardiol 1982;49:1758-66   DOI   ScienceOn
18 Asai T. Evaluation method for the degree of serious in Kawasaki disease. Acta Pediatr Jpn 1983;25:170-5   DOI
19 Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG. Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 1987;141:420-5
20 Fujiwara T, Fujiwara H, Nakano H. Pathological features on coronary arteries in children with Kawasaki disease in which coronary artery aneurysm was absent at autopsy. Circulation 1988;78:345-50   DOI   ScienceOn
21 Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 1986;315: 341-7   DOI   ScienceOn
22 Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-7
23 Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease : Review of risk factors for coronary aneurysms. J Pediatr 1986;108:388-92   DOI   PUBMED
24 Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease : US/Canadian Kawasaki Syndrome Study Group. Pediatr Infec Dis J 1998;17:1144-8   DOI   ScienceOn
25 Newburger JW, Burns JC. Kawasaki syndrome. Cardiol Clin 1989;7:453-65
26 Yanagisawa M, Kobayashi N, Matsuya S. Myocardial infarction due to coronary thromboarteritis following acute febrile mucocutaneous lymph node syndrome(MLNS) in an infant. Pediatrics 1974;54:277-81
27 Kamiya T, Suzuki A, Kijima Y, Hirose O, Tagahashi O. Coronary arterial lesion in Kawasaki disease : occurrence and prognosis. Rec Adv Cardiovascu Dis 1982;3:19-27
28 Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous $\gamma$-globulin treatment in Kawasaki disease. J Pediatr 2000;137: 177-80   DOI   ScienceOn
29 Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome(MLNS) prevailing in Japan. Pediatrics 1974;54: 271-6
30 Harada K. Intravenous $\gamma$-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10   DOI
31 Hong DE, Lee KY, Han JW, Hwang SS, Lee KS, Treatment of intravenous immune-globulin resistant Kawasaki disease with corticosteroids. J Korean Pediatr Soc 1997; 40:1453-7
32 Kato H, Inoue O, Akagi T. Kawasaki disease. Cardiac problems and magagement. Pediatr Rev 1988;9:209-17   DOI   ScienceOn
33 Nakano H, Ueda K, Nojima K, Saito A. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 1985;56:846-51   DOI   ScienceOn
34 Daniels SR, Specker B, Capannari TE, Schwartz DC, Burke MJ, Kaplan S. Correlate of coronary artery aneurysm formation in patients with Kawasaki disease. Am J Dis Child 1987;141:205-7
35 Ichida F, Fatica NS, Engle MA, O'Loughlin JE, Klein AA, Snyder MS. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York : Risk factors and role of aspirin. Pediatrics 1987;80:828-35
36 Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous $\gamma$-globulin treatment in Kawasaki disease. J Pediatr 2000;137: 177-80   DOI   ScienceOn
37 Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matsumoto Y, et al. Prediction of non-responsiveness to intravenous high-dose gammaglobulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000; 137:172-6   DOI   ScienceOn